Quantcast
 
New ETF Book by Larry Connors - Click here to read more


 

JMP Securities Healthcare to Host Conference

Wed. September 30, 2009; Posted: 11:12 PM
Stocks RSS
Sep 30, 2009 (Close-Up Media via COMTEX) -- JMP | Quote | Chart | News | PowerRating -- JMP Group Inc., an investment banking and alternative asset management firm, announced that JMP Securities will host the fourth annual JMP Securities Healthcare Focus Conference at The New York Palace hotel on Monday and Tuesday, October 5 and 6.

In a release, the Company noted event details:

The two-day conference will feature presentations to an audience of institutional investors and financial sponsors by senior executives of nearly 90 public and private companies representing the biotechnology, medical devices, healthcare services and healthcare information technology industries.

For additional details or to register to attend the event: jmpsecurities.com/about/events.html or contact your JMP Securities institutional sales representative.

Companies scheduled to present as of September 29:

Acadia Pharmaceuticals Inc.

Acceleron Pharma, Inc.

Agendia

Alexza Pharmaceuticals, Inc.

Allos Therapeutics, Inc.

Allscripts-Misys Healthcare Solutions, Inc.

Alnylam Pharmaceuticals, Inc.

American CareSource Holdings, Inc.

Anadys Pharmaceuticals, Inc.

Ardea Biosciences, Inc.

athenahealth, Inc.

AtriCure, Inc.

AVEO Pharmaceuticals, Inc.

AVI BioPharma, Inc.

BG Medicine, Inc.

BioCryst Pharmaceuticals, Inc.

Brookdale Senior Living Inc.

Cadence Pharmaceuticals, Inc.

CardioDx, Inc.

Cardiome Pharma Corp.

Celera Corp.

Celgene Corp.

Chemed Corp.

Clinical Data, Inc.

CombinatoRx, Inc.

CONMED Corp.

Corcept Therapeutics Inc.

Cyberonics, Inc.

Cytokinetics, Inc.

DexCom, Inc.

Dialysis Corp. of America

Dyax Corp.

Echo Therapeutics, Inc.

Enanta Pharmaceuticals, Inc.

Genomic Health, Inc.

Given Imaging Ltd.

GlobeImmune, Inc.

Greatbatch, Inc.

Healthways, Inc.

Human Genome Sciences, Inc.

Idenix Pharmaceuticals, Inc.

ImmuPharma plc

Impax Laboratories, Inc.

Incyte Corp.

InfuSystem Holdings, Inc.

Insulet Corp.

Integra LifeSciences Holdings Corp.

InterMune, Inc.

InTouch Technologies, Inc.

Inverness Medical Innovations, Inc.

Isis Pharmaceuticals, Inc.

Kensey Nash Corp.

LipoScience, Inc.

LTC Properties, Inc.

MannKind Corp.

MedAssets, Inc.

Myriad Genetics, Inc.

NeurogesX, Inc.

NuVasive, Inc.

Odyssey HealthCare, Inc.

Optimer Pharmaceuticals, Inc.

Orexigen Therapeutics, Inc.

Orthofix International N.V.

Osiris Therapeutics, Inc.

Pharmasset, Inc.

Precision Therapeutics, Inc.

PTC Therapeutics, Inc.

Quality Systems, Inc.

RadNet, Inc.

Rockwell Medical Technologies, Inc.

RTI Biologics, Inc.

S*BIO Pte Ltd.

Salix Pharmaceuticals, Ltd.

Sangamo BioSciences, Inc.

Savient Pharmaceuticals, Inc.

Seattle Genetics, Inc.

Silverado Senior Living, Inc.

SXC Health Solutions Corp.

Symmetry Medical Inc.

TargeGen, Inc.

Tethys Bioscience, Inc.

Transcend Services, Inc.

Vertex Pharmaceuticals Inc.

ViroPharma Inc.

Vivus, Inc.

XDx, Inc.

Ziopharm Oncology, Inc.

((Comments on this story may be sent to health@closeupmedia.com))

For full details for JMP click here.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Most Popular News
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.